Unknown

Dataset Information

0

Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.


ABSTRACT: MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumorigenesis. Due to the difficulty in drugging MYCN directly, revealing the molecules in MYCN regulatory networks will help to identify effective therapeutic targets for neuroblastoma therapy. Here we perform ChIP-sequencing and small RNA-sequencing of neuroblastoma cells to determine the MYCN-binding sites and MYCN-associated microRNAs, and integrate various types of genomic data to construct MYCN regulatory networks. The overall analysis indicated that MYCN-regulated genes were involved in a wide range of biological processes and could be used as signatures to identify poor-prognosis MYCN-non-amplified patients. Analysis of the MYCN binding sites showed that MYCN principally served as an activator. Using a computational approach, we identified 32 MYCN co-regulators, and some of these findings are supported by previous studies. Moreover, we investigated the interplay between MYCN transcriptional and microRNA post-transcriptional regulations and identified several microRNAs, such as miR-124-3p and miR-93-5p, which may significantly contribute to neuroblastoma pathogenesis. We also found MYCN and its regulated microRNAs acted together to repress the tumor suppressor genes. This work provides a comprehensive view of MYCN regulations for exploring therapeutic targets in neuroblastoma, as well as insights into the mechanism of neuroblastoma tumorigenesis.

SUBMITTER: Hsu CL 

PROVIDER: S-EPMC5095001 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.

Hsu Chia-Lang CL   Chang Hsin-Yi HY   Chang Jen-Yun JY   Hsu Wen-Ming WM   Huang Hsuan-Cheng HC   Juan Hsueh-Fen HF  

Oncotarget 20160601 24


MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumorigenesis. Due to the difficulty in drugging MYCN directly, revealing the molecules in MYCN regulatory networks will help to identify effective therapeutic targets for neuroblastoma therapy. Here we perform ChIP-sequencing and small RNA-sequencing of neuroblastoma cells to determine the MYCN-binding sites and MYCN-associated microRNAs, and integrate various types of genomic data to construct MYCN re  ...[more]

Similar Datasets

| S-EPMC3495658 | biostudies-literature
| S-EPMC5988829 | biostudies-literature
| S-EPMC4837470 | biostudies-literature
| S-EPMC3636059 | biostudies-literature
| S-EPMC3130556 | biostudies-literature
| S-EPMC3320515 | biostudies-literature
| S-EPMC4949549 | biostudies-literature
| S-EPMC7321810 | biostudies-literature
| S-EPMC9990262 | biostudies-literature
| S-EPMC4126456 | biostudies-literature